Imunon (IMNN) Other financing activities (2011 - 2025)

Imunon's (IMNN) quarterly Other financing activities came in at $1.0 in Q4 2025, down 100.0% on a QoQ basis from $1.5 million in Q1 2021.

Imunon (IMNN) Other financing activities (2011 - 2025) Analysis & Trends

Imunon (IMNN) has 6 years of Other financing activities data on file, last reported at $1.0 in Q4 2025.

Quarterly Other financing activities changed N/A year-over-year to $1.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 (changed N/A YoY) and the FY2025 annual result came in at $3.5 million, changed N/A from the prior year.
Other financing activities slipped to $1.0 in Q4 2025, from $1.5 million in the prior quarter.
In the past five years, Other financing activities ranged from a high of $1.5 million in Q1 2021 to a low of $1.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Imunon	8.16 Mn	8.16 Mn	-

Download Data